Quantum Biopharma (QNTM) Capital Expenditures (2019 - 2026)
Quantum Biopharma (QNTM) reported Capital Expenditures of -$3.0 million for Q1 2026, down 5.79% on a YoY basis from -$3.1 million in Q1 2025, and down 234.76% sequentially from -$884881.0 in Q3 2025.
Quantum Biopharma (QNTM) Capital Expenditures (2019 - 2026) Analysis & Trends
Quantum Biopharma (QNTM) has 7 years of Capital Expenditures data on file, last reported at -$3.0 million in Q1 2026.
- For the quarter ending Q1 2026, Capital Expenditures fell 5.79% year-over-year to -$3.0 million; the trailing twelve-month figure through Mar 2026 stood at -$8.1 million (down 191.38% YoY), and the FY2022 full-year result was $113958.0, changed N/A from the prior year.
- Capital Expenditures retreated to -$3.0 million in Q1 2026, from -$884881.0 in the prior quarter.
- In the past five years, Capital Expenditures ranged from a high of $3.5 million in Q4 2024 to a low of -$3.5 million in Q3 2024.
- A 5-year average of -$570015.1 and a median of -$59528.5 in 2022 frame the typical range for Capital Expenditures.
- Across the five-year window, Capital Expenditures soared 368.16% in 2024 and sank 651924.32% in 2025, its largest moves.
- Tracing QNTM's Capital Expenditures over 5 years: stood at $230839.0 in 2022, then soared by 222.52% to $744500.0 in 2023, then soared by 368.16% to $3.5 million in 2024, then plunged by 125.39% to -$884881.0 in 2025, then plunged by 234.76% to -$3.0 million in 2026.
- Business Quant data shows QNTM's Capital Expenditures at -$3.0 million in Q1 2026, -$884881.0 in Q3 2025, and -$1.4 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -8,939.03 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 43.25 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 133.40 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 230.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 786,000.00 |
| 10 | Quantum Biopharma | 2.61 Bn | 2.60 Bn | - | -2.96 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.96 Mn |
| Mar 31, 2026 | -2.96 Mn |
| Sep 30, 2025 | -884,881.00 |
| Sep 30, 2025 | -884,881.00 |
| Jun 30, 2025 | -1.45 Mn |
| Jun 30, 2025 | -1.45 Mn |
| Mar 31, 2025 | -2.80 Mn |
| Mar 31, 2025 | -2.80 Mn |
| Dec 31, 2024 | 3.49 Mn |
| Dec 31, 2024 | 3.49 Mn |
| Sep 30, 2024 | -3.46 Mn |
| Sep 30, 2024 | -3.46 Mn |
| Jun 30, 2024 | 222.00 |
| Jun 30, 2024 | 222.00 |
| Mar 31, 2024 | -22,140.00 |
| Mar 31, 2024 | -22,140.00 |
| Dec 31, 2023 | 744,500.00 |
| Dec 31, 2023 | 744,500.00 |
| Sep 30, 2023 | -744,500.00 |
| Sep 30, 2023 | -744,500.00 |